Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1985 Mar;51(3):335-45.
doi: 10.1038/bjc.1985.45.

Tumourigenic phenotypes of human melanoma cell lines in nude mice determined by an active antitumour mechanism

Free PMC article

Tumourigenic phenotypes of human melanoma cell lines in nude mice determined by an active antitumour mechanism

R Jacubovich et al. Br J Cancer. 1985 Mar.
Free PMC article

Abstract

Ten human melanoma cell lines (HMCL) were tested for their ability to grow subcutaneously in nude mice. Using a standard inoculum, the HMCL could be characterized by their highly, fairly or poorly xenografting phenotype. These phenotypes were stable and the phenotype of one HMCL was recovered within cell clones derived from it. The role of nude mice natural defences in the expression of HMCL xenografting phenotypes was studied. Sublethal whole body irradiation and silica pretreatment of recipients enabled poorly tumourigenic HMCL to grow in most animals without affecting their splenic NK activity. Admixture of BCG or MDP encapsulated in liposomes with highly tumourigenic HMCL resulted in the abrogation of tumour growth in naive nude mice. The long lasting abrogating of NK activity in vivo by treatment with anti-asialo-GM1 anti-serum did not enhance the growth of a poorly tumourigenic HMCL. The HMCL were found to be resistant to in vitro murine NK activity. These results showed that the expression of the HMCL xenografting phenotypes could be controlled by the nude mice natural defences. NK cells did not seem to be largely involved whereas macrophages might be good candidates as anti-xenograft effectors.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Exp Med. 1966 Aug 1;124(2):141-54 - PubMed
    1. J Natl Cancer Inst. 1984 May;72(5):1029-38 - PubMed
    1. Exp Cell Res. 1974 Mar 15;84(1):311-8 - PubMed
    1. Int J Cancer. 1976 Jan 15;17(1):82-9 - PubMed
    1. Cancer. 1976 May;37(5):2158-76 - PubMed

Substances